I haven't thought about this deeply but I would have thought...

I haven't thought about this deeply but I would have thought that doing a raise on top of the Lanstead deal might be a bit of a challenge. The deal is due to run until something like Feb 2019, I think. The current funding should finish everything off (toxicity, manufacturing, planning Ph III) up to the start of Ph III.

So here's one possible (non deal) timeline: in September or October or so, they announce commencement of Ph III and some sort of funding arrangement to support it, starting in Feb-Mar 2019.